8 results
Perianal Crohn's Disease - IBD Algorithm

 • 5-40% w perianal fistula
 • ↑ risk if colonic
Perianal Crohn's Disease ... - IBD Algorithm ... refractory to medical therapy ... #IBDAlgorithm # ... gastroenterology
Dual Targeted Therapy (DTT) in IBD - IBD Algorithm

Indication for DTT:
 • Refractory
 • Failed multiple
Dual Targeted Therapy ... ) in IBD - IBD Algorithm ... Severe/Extensive Disease ... #IBDAlgorithm # ... gastroenterology
Overall Approach to Anemia - Differential Diagnosis Algorithm

Blood Loss
 • Acute Bleed - Normocytic / Normochromic
Differential Diagnosis Algorithm ... Anemia of Chronic Disease ... • RBC Membrane Disorder ... Non-lmmune #Anemia #Classification ... #Causes #Hematology
Dysphagia - Differential Diagnosis Framework

Symptom | Diagnosis
• Solid-food dysphagia present for months to years | Mechanical
stroke, Parkinson disease ... adjustment and speech therapy ... • Therapy for ... the underlying cause ... Diagnosis #Management #gastroenterology
Algorithm regarding the diagnosis and treatment of Hereditary Hemochromatosis HH. 

Step 1: In the patient with
Algorithm regarding ... of liver disease ... and hematologic disorders ... hemochromatosis #algorithm ... management #hepatology #gastroenterology
Protein Losing Enteropathy
Clinical Presentation:
 • Volume overload: Peripheral edema, pleural effusion or ascites.
 • Gl symptoms
if underlying disease ... without apparent cause ... Amyloidosis • Disorders ... Treatment: • Dietary therapy ... diagnosis #management #gastroenterology
Achalasia Summary

Epidemiology: 10 cases per 100,000 individuals

Defined by inadequate relaxation of the LES and aperistalsis
Primary or
achalasia is due to diseases ... Neurodegenerative disorders ... esophageal motility disorders ... the first-line therapy ... management #treatment #gastroenterology
Monoclonal Gammopathy of Renal Significance (MGRS)

MGRS
• MGRS refers to kidney disease caused by nephrotoxic monoclonal immunoglobulins
caused by nephrotoxic ... or plasma cell disorder ... guide subtype classification ... Clone-directed therapy ... Rituximab-based therapy